Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Akihiro Hirakawa
Institution:
Institute of Science Tokyo
Observed institution:
Institute of Science Tokyo
ORCID:
0000-0003-2580-7460
Observed ORCID:
0000-0003-2580-7460
OpenAlex ID:
A5124449404
Bayesian interpretation of febrile neutropenia risk and primary granulocyte colony-stimulating factor prophylaxis during darolutamide triplet therapy
2026
·
Hiroshi Fukushima
, Soichiro Yoshida
, et al.
·
Japanese Journal of Clinical Oncology
·
1
Heterogeneity in Treatment Effects of Reduced Versus Standard Dose of Cabazitaxel in Metastatic Castration‐Resistant Prostate Cancer
2026
·
Wataru Fukuokaya
, Keiichiro Mori
, et al.
·
Cancer Medicine
·
1
PDF
Real‐World Comparison of Triplet Versus Doublet Therapy in Japanese Patients With High‐Volume Metastatic Hormone‐Sensitive Prostate Cancer: A Propensity‐Weighted Analysis From the YUSHIMA Registry and Exploratory Bayesian Evidence Synthesis
2026
·
Yosuke Yasuda
, Soichiro Yoshida
, et al.
·
The Prostate
Evaluation of Growth and Development of the External Auditory Canal Using 624 Temporal Bone Computed Tomography Scans for Appropriate Cochlear Gene Delivery
2026
·
Kazuki Matsuura
, Hidekane Yoshimura
, et al.
·
Otology & Neurotology
Toward development of guidelines for clinical evaluation of amyotrophic lateral sclerosis therapeutics
2025
·
Koji Fujita
, Masashi Aoki
, et al.
·
Journal of the Neurological Sciences
Show more works
View as search
Works count:
5
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type